Physician profile
Anna Lange
NPI 1962875310
$3,966.68
in general payments reported to CMS, 2019-2025
17 companies · $698 in 2025
The $698 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,122 · 2020: $275 · 2021: $1,117 · 2022: $687 · 2023: $39.09 · 2024: $28.48 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $993.79 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $572.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $317.31 | 2019-2023 | |
| Harrow Eye, LLC | $288.02 | 2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $265.75 | 2019-2025 | Acuvue |
| Horizon Therapeutics Plc | $242.96 | 2021-2022 | |
| Glaukos Corporation | $242.19 | 2021 | |
| Shire North American Group INC | $195.92 | 2019 | |
| Oyster Point Pharma, INC. | $145.60 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.75 | 2019-2021 | |
| Coopervision INC. | $124.84 | 2022-2025 | Myday Contact Lens, Misight Contact Lens |
| Dompe US, INC. | $123.86 | 2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $122.24 | 2019 | |
| Bausch & Lomb Americas INC. | $115.56 | 2025 | Xiidra, Miebo |
| Kala Pharmaceuticals, INC. | $31.55 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $23.26 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Lange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.